Kuang Junliang, Zheng Xiaojiao, Huang Fengjie, Wang Shouli, Li Mengci, Zhao Mingliang, Sang Chao, Ge Kun, Li Yitao, Li Jiufeng, Rajani Cynthia, Ma Xiaohui, Zhou Shuiping, Zhao Aihua, Jia Wei
Center for Translational Medicine and Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.
Metabolites. 2020 Nov 23;10(11):475. doi: 10.3390/metabo10110475.
Theabrownin is one of the most bioactive compounds in Pu-erh tea. Our previous study revealed that the hypocholesterolemic effect of theabrownin was mediated by the modulation of bile salt hydrolase (BSH)-enriched gut microbiota and bile acid metabolism. In this study, we demonstrated that theabrownin ameliorated high-fat-diet (HFD)-induced obesity by modifying gut microbiota, especially those with 7α-dehydroxylation on the species level, and these changed microbes were positively correlated with secondary bile acid (BA) metabolism. Thus, altered intestinal BAs resulted in shifting bile acid biosynthesis from the classic to the alternative pathway. This shift changed the BA pool by increasing non-12α-hydroxylated-BAs (non-12OH-BAs) and decreasing 12α-hydroxylated BAs (12OH-BAs), which improved energy metabolism in white and brown adipose tissue. This study showed that theabrownin was a potential therapeutic modality for obesity and other metabolic disorders via gut microbiota-driven bile acid alternative synthesis.
茶褐素是普洱茶中生物活性最强的化合物之一。我们之前的研究表明,茶褐素的降胆固醇作用是通过调节富含胆汁盐水解酶(BSH)的肠道微生物群和胆汁酸代谢来实现的。在本研究中,我们证明茶褐素通过改变肠道微生物群,尤其是在物种水平上具有7α-脱羟基作用的微生物群,改善了高脂饮食(HFD)诱导的肥胖,并且这些变化的微生物与次级胆汁酸(BA)代谢呈正相关。因此,肠道BA的改变导致胆汁酸生物合成从经典途径转变为替代途径。这种转变通过增加非12α-羟基化胆汁酸(non-12OH-BAs)和减少12α-羟基化胆汁酸(12OH-BAs)来改变BA池,从而改善白色和棕色脂肪组织中的能量代谢。本研究表明,茶褐素是一种通过肠道微生物群驱动的胆汁酸替代合成来治疗肥胖和其他代谢紊乱的潜在治疗方式。